maplightrx.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $288MM
Maplight Therapeutics is a drug discovery platform utilizing transcriptomics and optogenetics to find treatments for brain disorders and symptoms.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/30/2023 | Series C | $225MM | $xx.xx | $457.61MM | Novo Holdings, 5AM Ventures, Cowen Healthcare Investments | |
Price per Share
$xx.xx
Shares Outstanding
147,325,537
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Novo Holdings, 5AM Ventures, Cowen Healthcare Investments
|
||||||
10/25/2022 | Series B-1 | $12MM | $xx.xx | $246.63MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,622,496
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
10/23/2021 | Series B | $30MM | $xx.xx | $118.86MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
25,477,576
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/23/2019 | Series A-1 | $16MM | $xx.xx | $61.01MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,946,844
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
02/22/2019 | Series A | $5MM | $xx.xx | $20MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|